Please provide your email address to receive an email when new articles are posted on . Vuity has been available for more than a year, in which time we have learned a lot about this modality for ...
About a year ago, the U.S. Food and Drug Administration authorized the first eye drop that could be used to improve the vision of people with a condition called presbyopia — the term doctors use for ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first pharmacological drug for the treatment of presbyopia in October 2021. Vuity from ...
The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a common age-related condition that causes blurry vision. Local ...
(RTTNews) - Allergan, an AbbVie (ABBV) company, announced Tuesday that the Phase 3 VIRGO trial evaluating the safety and efficacy of investigational twice-daily administration of VUITY (pilocarpine ...
If you’re over age 40 and find yourself squinting to make out small print right in front of you, you’re not alone. More than 128 million Americans live with normal, age-related loss of their near ...
A new drug that hit the market Thursday has the potential to offer middle-aged people freedom from reading glasses. The drug, pilocarpine, is being sold under the brand name Vuity by drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results